Hot Obesity Drug Market Will Keep Investors Gripped Next Year

Published on 23 Dec 2024 on Bloomberg · via Yahoo Finance

(Bloomberg) -- Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot capped a...

Read the rest of the article

Start tracking your investments with Statfolio

Viking Therapeutics, Inc. (VKTX) closed the latest trading day at $42.68, indicating a +0.78% cha...

Zacks · via Yahoo Finance 27 Dec 2024

We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we...

Insider Monkey · via Yahoo Finance 25 Dec 2024

(Bloomberg) -- Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot cappe...

Bloomberg · via Yahoo Finance 23 Dec 2024

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we...

Insider Monkey · via Yahoo Finance 23 Dec 2024

The most recent trading session ended with Viking Therapeutics, Inc. (VKTX) standing at $42.25,...

Zacks · via Yahoo Finance 20 Dec 2024

CT-388, a dual GLP-1/GIP receptor agonist, is being evaluated for the treatment of obesity in pat...

Zacks · via Yahoo Finance 19 Dec 2024

On Wednesday, Merck & Co Inc (NYSE:MRK) and Hansoh Pharma, a Chinese biopharmaceutical company,...

Benzinga · via Yahoo Finance 19 Dec 2024

Nvidia, Jabil Surge Among Market Cap Stock Movers on Wednesday

Investing.com 19 Dec 2024

Nvidia, Jabil Surge Among Market Cap Stock Movers on Wednesday

Investing.com 19 Dec 2024

On Wednesday, Merck & Co Inc (NYSE:MRK) and Hansoh Pharma, a Chinese biopharmaceutical company,...

Benzinga · via AOL 18 Dec 2024